Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2024-07-04 | 2024-05-31 |
| Drug Identification Number | 00533688 | 00533688 |
| Brand name | TOBRAMYCIN FOR INJECTION | TOBRAMYCIN FOR INJECTION |
| Common or Proper name | TOBRAMYCIN FOR INJECTION | TOBRAMYCIN FOR INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | TOBRAMYCIN | TOBRAMYCIN |
| Strength(s) | 1.2G | 1.2G |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 50mL | 50mL |
| ATC code | J01GB | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | ||
| Actual start date | 2024-06-01 | 2024-06-01 |
| Estimated end date | 2024-07-05 | 2024-07-05 |
| Actual end date | 2024-07-02 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our Tobramycin for Injection 1.2 g powder PBP Vial 50 mL effective June 1, 2024 until July 5, 2024. During this time, our Tobramycin Injection 40 mg/mL MD Vial 30 mL is available for substitution. | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our Tobramycin for Injection 1.2 g powder PBP Vial 50 mL effective June 1, 2024 until July 5, 2024. During this time, our Tobramycin Injection 40 mg/mL MD Vial 30 mL is available for substitution. |
| Health Canada comments |